Japanese Encephalitis Vaccine (JEV)
Closed Pre-Solicitation Posted
A later notice was posted. The latest for this opportunity is the Limited / Sole Source Justification from . See the latest notice
- Solicitation number
- SPE2DP-24-R-0002
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Philadelphia, Pennsylvania 19111, United States
- Points of contact
-
- Jessica Delahoz jessica.delahoz@dla.mil (445) 737-3623
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) under Solicitation Number SPE2DP-24-R-0002. The contract will be a firm-fixed price, indefinite delivery/indefinite quantity type with a one-year base term. The estimated quantity is 208,320 EA, with a minimum of 200,060 EA and a maximum of 300,300 EA. Delivery will be FOB Destination to the DLA Distribution Susquehanna facility in New Cumberland, PA. The successful contractor must have FDA approval to sell JEV prior to award.
This procurement is not set-aside. All responsible sources may submit a proposal and shall be considered by the Agency. The proposed contract has a production lead time of 120 days after issuance of the delivery order. The solicitation is expected to be issued on or around May 2024, with a due date of August 28, 2024. The NAICS code is 325414 - Biological Product (except Diagnostic) Manufacturing, and the PSC is 6505 - Drugs And Biologicals.
Notice text
Solicitation: SPE2DP-24-R-0002
Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV)
NSN: 6505-01-607-7018
Description:
The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 4 dated 30 January 2020, which is attached to this notice.
The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1), only one responsible source.
The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2).
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a one-year base term. The minimum quantity is 200,060 EA. The estimated quantity is 208,320 EA. The maximum quantity is 300,300 EA.
Inspection/Acceptance at Destination
FOB Destination
Delivery Destination:
DODAAC: SV3100
DLA Distribution Susquehanna
U Avenue, Bldg. 89, Door 6
New Cumberland, PA 17070
Attn: Jim Earp
Production Lead Time is 120 days after issuance date of the delivery order (DD1155).
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell JEV before award decision.
****************************************************************************
IMPORTANT NOTICES
Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024.
******************************************************************************
Attachments
| File | Type | Posted |
|---|---|---|
| JEV_MPID 4_30Jan2020.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Japanese Encephalitis Vaccine (JEV) | Limited / Sole Source Justification | |
| Japanese Encephalitis Vaccine (JEV) | Pre-Solicitation | |
| Japanese Encephalitis Vaccine (JEV) | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity